Eton Pharmaceuticals, Inc.
Recent Filings
All 360 filings →Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Gruber James R. | Chief Financial Officer | Sale | 39,082 @ $16.16 | 205,299 | Aug 20, 2025 |
| Krempa David | Chief Business Officer | Sale | 6,800 @ $14.77 | 622,869 | Jun 16, 2025 |
| Opaleye Management Inc. | — | Purchase | 5,000 @ $15.82 | 2,770,000 | Jun 10, 2025 |
| BRYNJELSEN SEAN | President & CEO | Sale | 400 @ $19.02 | 3,013,513 | Jun 4, 2025 |
| Opaleye Management Inc. | — | Purchase | 10,000 @ $7.98 | 2,770,000 | Oct 23, 2024 |
| Opaleye Management Inc. | — | Purchase | 15,000 @ $6.77 | 2,720,000 | Oct 8, 2024 |
| Opaleye Management Inc. | — | Purchase | 7,500 @ $4.65 | 70,000 | Sep 10, 2024 |
| BRYNJELSEN SEAN | Chief Executive Officer | Purchase | 10,000 @ $2.10 | 1,040,000 | Sep 22, 2022 |
| Opaleye Management Inc. | — | Sale | 25,000 @ $4.67 | 2,375,000 | Nov 17, 2021 |
| Opaleye Management Inc. | — | Sale | 11,500 @ $4.86 | 2,400,000 | Nov 16, 2021 |